ES2032838T3 - Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol. - Google Patents

Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol.

Info

Publication number
ES2032838T3
ES2032838T3 ES198787311330T ES87311330T ES2032838T3 ES 2032838 T3 ES2032838 T3 ES 2032838T3 ES 198787311330 T ES198787311330 T ES 198787311330T ES 87311330 T ES87311330 T ES 87311330T ES 2032838 T3 ES2032838 T3 ES 2032838T3
Authority
ES
Spain
Prior art keywords
tetrahydropiride
indol
derivatives
preparing
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787311330T
Other languages
English (en)
Inventor
Dagmar Beecham-Wuelfing Gmbh & Co Kg. Hoeltje
Ljerka Beecham-Wuelfing Gmbh & Co Kg. Jozic
Dietrich Beecham-Wuelfing Gmbh & Co Kg. Thielke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Wuelfing GmbH and Co KG
Original Assignee
Beecham Wuelfing GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868630635A external-priority patent/GB8630635D0/en
Priority claimed from GB878720946A external-priority patent/GB8720946D0/en
Application filed by Beecham Wuelfing GmbH and Co KG filed Critical Beecham Wuelfing GmbH and Co KG
Application granted granted Critical
Publication of ES2032838T3 publication Critical patent/ES2032838T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

COMPOSICION FARMACOLOGICA QUE CONTIENE UN COMPUESTO DE FORMULA (I) O UNA SAL FARMACOLOGICAMENTE ACEPTABLE DEL MISMO DONDE R1, R2, R3, R4, R5, R6 TIENEN EL SIGNIFICADO QUE SE INDICA EN LA DESCRIPCION.
ES198787311330T 1986-12-22 1987-12-22 Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol. Expired - Lifetime ES2032838T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868630635A GB8630635D0 (en) 1986-12-22 1986-12-22 Active compounds
GB878720946A GB8720946D0 (en) 1987-09-05 1987-09-05 Active compounds

Publications (1)

Publication Number Publication Date
ES2032838T3 true ES2032838T3 (es) 1993-03-01

Family

ID=26291727

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787311330T Expired - Lifetime ES2032838T3 (es) 1986-12-22 1987-12-22 Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol.

Country Status (11)

Country Link
US (1) US4968699A (es)
EP (1) EP0279125B1 (es)
KR (1) KR930006777B1 (es)
AU (1) AU610105B2 (es)
CA (1) CA1329597C (es)
DE (1) DE3778685D1 (es)
DK (1) DK674187A (es)
ES (1) ES2032838T3 (es)
GR (1) GR3004470T3 (es)
NZ (1) NZ223018A (es)
PT (1) PT86424B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1043991A4 (en) * 1997-11-14 2005-02-02 Lilly Co Eli TREATMENT OF ALZHEIMER DISEASE
EP1132389A1 (en) 2000-03-06 2001-09-12 Vernalis Research Limited New aza-indolyl derivatives for the treatment of obesity
MX2007005199A (es) 2004-11-01 2007-05-11 Wyeth Corp Indolizinas sustituidas y derivados como agentes del sistema nervioso central.
WO2014023397A2 (de) 2012-08-06 2014-02-13 Merck Patent Gmbh Tensidmischungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5337696A (en) * 1976-08-26 1978-04-06 Omnium Chimique Sa Hexahydrocantinonee6 derivative
GB1550496A (en) * 1976-12-31 1979-08-15 Logeais Labor Jacques 1,2,3,3a4,5-hexahydro-canthine derivatives a process for their preparation and their therapeutic applications
FR2475394A1 (fr) * 1980-02-12 1981-08-14 Synthelabo Compositions pharmaceutiques contenant l'hexahydro-1, 2, 3, 3a, 4, 5, 6h indolo (3, 2, 1 - d. e) (1, 5) naphtyridinone - 6
GB8416724D0 (en) * 1984-06-30 1984-08-01 Sorbio Sa Lab Active compounds
DE3677101D1 (de) * 1985-06-28 1991-02-28 Beecham Wuelfing Gmbh & Co Kg Tetrahydropyrido-(1,2-a)-indolderivate, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.

Also Published As

Publication number Publication date
PT86424B (pt) 1990-11-20
EP0279125A1 (en) 1988-08-24
DK674187A (da) 1988-06-23
KR890005097A (ko) 1989-05-11
AU610105B2 (en) 1991-05-16
PT86424A (en) 1988-01-01
DK674187D0 (da) 1987-12-21
EP0279125B1 (en) 1992-04-29
US4968699A (en) 1990-11-06
DE3778685D1 (de) 1992-06-04
CA1329597C (en) 1994-05-17
AU8286487A (en) 1988-06-23
GR3004470T3 (es) 1993-03-31
KR930006777B1 (ko) 1993-07-23
NZ223018A (en) 1991-06-25

Similar Documents

Publication Publication Date Title
ES2067456T3 (es) Nuevos derivados de aminoacidos, procedimientos para su preparacion y composicion farmaceutica que los comprende.
LU90856I2 (fr) Uprima - apomorphine hydrochloride et ses d-riv-s pharmaceutiquement acceptables
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
MX9102582A (es) Derivados de indol 3,7-disubstituidos, procedimiento para su preparacion y composicion farmaceutica que los contiene.
TW333527B (en) Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
ATE38991T1 (de) In 2-stellung substituierte 1,3propyledendephosphonat-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
DK0406119T3 (da) Hidtil ukendte peptidderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
DK0692484T3 (da) Benzothiadiazinderivat, fremgangsmåde til fremstilling deraf samt farmaceutiske sammensætninger indeholdende derivatet
ES2091310T3 (es) Nuevos derivados de la n-benzoil-prolina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
SE8302979L (sv) Piperazinderivat, deras framstellning och farmaceutiska kompositioner innehallande dessa
ES2032838T3 (es) Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol.
ES2046528T3 (es) Derivados heterotetraciclicos de lactamas, proceso para su preparacion y composiciones farmaceuticas a base de los mismos.
ES2117003T3 (es) Derivados oligopeptidicos de hipoxantina dotados de actividad inmunomoduladora, y composiciones farmaceuticas que los contienen.
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
ATE113949T1 (de) Alpha-adrenergische rezeptorantagonisten.
DK378087A (da) Tetracycliske indolderivater
ZW6889A1 (en) &-adrenergic receptor antagonists
IL67400A0 (en) 3,7alpha-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them
ES2032573T3 (es) Procedimiento de preparacion de derivados de 4,4-dimetil-tetrahidropir-2-ona.
ES2057121T3 (es) Antagonistas de los receptores alfa-adrenergicos.
NO885811D0 (no) Fremgangsmaate for fremstilling av 2-amino-tetrahydroisokinolinderivater.
GT199400041A (es) Derivados de n4 (oxicarbonil substituidos)-5'desoxi-5-fluorocitidina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 279125

Country of ref document: ES